Gender-related Responsiveness to the Pharmacological Treatment of COPD: A First Step Towards the Personalized Medicine

The post-hoc analysis of the data collected from the Lung Health Study supports the evolving concept that the impact of COPD may be different between men and women, and supports the hypothesis of a gender-related responsiveness to the pharmacological treatment of COPD. Specific translational studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Calzetta, Luigino, Puxeddu, Ermanno, Rogliani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440626/
https://www.ncbi.nlm.nih.gov/pubmed/28473238
http://dx.doi.org/10.1016/j.ebiom.2017.04.035
Descripción
Sumario:The post-hoc analysis of the data collected from the Lung Health Study supports the evolving concept that the impact of COPD may be different between men and women, and supports the hypothesis of a gender-related responsiveness to the pharmacological treatment of COPD. Specific translational studies are needed to assess the real gender-related impact of the currently available dual bronchodilation therapy on the lung function and clinical outcomes of COPD patients. This approach may represent the first affordable step towards a feasible personalized medicine.

Ejemplares similares